MAPT and Alzheimer disease: Recent studies61–64 suggest that Alzheimer's disease may have distinct biological features of tau spreading patterns, which are important for explaining the heterogeneity of tau-related neurodegeneration and cognitive decline and the design of anti-tau clinical trials.